BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, May 10, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 20, 2004
View Archived Issues
Small molecule VEGF antagonist inhibits tumor growth in vivo
Read More
Antiviral efficacy of a saquinavir-based HAART regimen in HIV-infected patients
Read More
Significant association found between coronary artery risk factors and erectile dysfunction
Read More
Rosiglitazone improves insulin activity and affects adipose cell turnover in obese rats
Read More
CancerVax licenses rights to SAI product candidates targeting EGFR
Read More
New phase IIb study of darusentan for resistant systolic hypertension
Read More
BioMimetic's GEM-21S recommended for approval
Read More
Phase IIb study of VEGF-2 for severe cardiovascular disease cleared to begin
Read More
Rotarix vaccine receives first global approval in Mexico
Read More
Neurobiological Technologies acquires Empire Pharmaceuticals, expanding pipeline with Viprinex
Read More
NDA for Xopenex HFA MDI accepted for review
Read More
Estorra NDA resubmission accepted by FDA
Read More
Indiplon NDA filings planned for fourth quarter 2004
Read More
I2S receives fast track status for Hunter's syndrome
Read More
First phase of topical ENT-103 formulation completed
Read More
European approval for Telzir for HIV
Read More
Aldara receives approval for superficial basal cell carcinoma
Read More
WF-10 fails to meet primary endpoints in phase III AIDS study
Read More
Good safety and pharmacokinetic profile of the antiretroviral GW-695634 in healthy volunteers
Read More
Safinamide improves motor function in patients with Parkinson's disease
Read More
Update on the safety, pharmacokinetics and antiviral effects of PA-457 in HIV infection
Read More
TGF-beta inhibitor claimed in Lilly patent
Read More
Takeda discloses melanin-concentrating hormone (MCH) antagonists
Read More
Inhibitors of hepatic gluconeogenesis in early development at Sumitomo
Read More
Tyropeptin A analogues with antitumor activity disclosed in patent
Read More
PTP-1B inhibitors for the treatment of insulin resistance
Read More
Xanthine derivatives under development at Sumitomo
Read More
Preclinical efficacy in a task sensitive to Alzheimer's disease
Read More